Dysregulated ATP1A1 expression has been reported in multiple cancers, including breast 29, gastric 30, colon 31, and non-small cell lung cancer (NSCLC) 32, where its suppression inhibits cell proliferation 30,31 and migration 31. This evidence concerns the gene ATP1A1 and cancer.